Evidence map›Paper›PMID 39852859›Full record

ArticleVaccines2025

Strengthening National Immunization Technical Advisory Groups: Twelve Years of Progress (2012-2023).

Louise Henaff, Laure Dumolard, Vinod Bura, Gerald Etapelong Sume, Sidy Ndiaye, Jennifer Sanwogou, Heeyoun Cho, Joachim Hombach, Christoph A Steffen

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Louise HenaffWorld Health Organization (WHO), 1211 Geneva, Switzerland.ORCID 0009-0003-9454-2192
Laure DumolardWorld Health Organization (WHO), 1211 Geneva, Switzerland.
Vinod BuraWorld Health Organization (WHO) Regional Office for South-East Asia, New Delhi 110002, India.
Gerald Etapelong SumeWorld Health Organization (WHO) Regional Office for the Eastern Mediterranean, Cairo 11371, Egypt.ORCID 0000-0002-2908-1719
Sidy NdiayeWorld Health Organization (WHO) Regional Office for Africa, Brazzaville P.O. Box 06, Congo.ORCID 0009-0009-0399-5182
Jennifer SanwogouWorld Health Organization (WHO) Regional Office for the Americas, Washington, DC 20037, USA.
Heeyoun ChoWorld Health Organization (WHO) Regional Office for the Western Pacific, Manila 1000, Philippines.ORCID 0000-0002-6125-9548
Joachim HombachWorld Health Organization (WHO), 1211 Geneva, Switzerland.ORCID 0000-0002-3271-6033
Christoph A SteffenWorld Health Organization (WHO), 1211 Geneva, Switzerland.ORCID 0000-0003-0777-5047

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionWell-functioning National Immunization Technical Advisory Groups (NITAGs) are valuable contributors to decision-making processes in the complex immunization policy arena. This paper describes the progress made globally on the establishment and strengthening of these key advisory groups and discusses some of their strengths, challenges, and opportunities.

methodsThe data submitted annually by countries to the World Health Organization (WHO) via the WHO/UNICEF Joint Reporting Form (JRF) were analyzed, comparing the NITAG functionality criteria in 2012 and 2023.

resultsIn 2023 and 2012, 88% and 61% of countries, respectively, reported having a NITAG. A total of 77% of NITAGs met all six NITAG process criteria in 2023 compared to 33% in 2012. This progress was most notable in the WHO African Region, increasing from 7% (2012) to 77% (2023), and the South-East Asia Region, increasing from 45% (2012) to 91% (2023). In 2023, 84% of NITAGs issued a vaccine-policy recommendation that was adopted by decision-makers. DISCUSSION: Marked progress has been made since 2012 on establishing and maintaining NITAGs, with a small number of countries yet to form an advisory committee. Supporting and sustaining NITAG functions remains an important means for countries to foster independent and transparent expert advice on vaccine and immunization policy. Setbacks in countries facing instability or political turmoil are a reminder of the reversibility of progress. WHO and partners play an important role in supporting countries in strengthening these advisory committees. Continuous commitment by countries to the function and involvement of NITAGs in policy recommendations is essential for enhancing the strength and resilience of immunization programs.

Indexed as

immunization policyNational Immunization Technical Advisory GroupsNITAGsWHO–UNICEF Joint Reporting Form

Identifiers

PMID39852859
PMCPMC11768658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.